Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Manitoba court dismisses class action against North West Co. over Nutrition North subsidy claims

Market News
19 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

The Manitoba Court of King’s Bench has dismissed a proposed class action lawsuit against The North West Company, which alleged the company misrepresented how much of the Nutrition North Canada subsidy it passed to consumers. The lawsuit claimed negligent misrepresentation and other breaches but was struck down after the company argued the claim had no legal merit. The North West Company maintains it complies with government subsidy rules and continues to urge improvements to the Nutrition North program to better support northern communities. The court’s detailed reasons for the dismissal will be released later.

More News

CN Energy's Pathenbot launches intelligent robotic cargo sorting in the US with a 100,000-unit order.

CN Energy's Pathenbot launches intelligent robotic cargo sorting in the US with a 100,000-unit order.

CN Energy Group's subsidiary Pathenbot has signed an order to provide intelligent robotic cargo sorting services in the United States, marking the commercial launch of these services. The initial order covers 100,000 units and includes barcode scanni...

Market News
Bullish
53 minutes ago
US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures gained as investors reacted to positive earnings from companies like Ross Stores, Zoom, and Take-Two Interactive, alongside cautious optimism about US-Iran peace talks. However, uncertainty remains due to Iran's firm stance on uraniu...

Company Fundamentals
Bullish
1 hour ago
BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech presented encouraging clinical data for its late-stage cancer drug candidates Pumitamig and Gotistobart at the ASCO 2026 meeting. Pumitamig showed promising anti-tumor activity in a Phase 2/3 study for first-line treatment of non-small cell ...

Market News
Bullish
1 hour ago
BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech will showcase new clinical data for its late-stage oncology drugs pumitamig and gotistobart at the 2026 ASCO Annual Meeting. Pumitamig showed encouraging anti-tumor activity in first-line non-small cell lung cancer, while gotistobart demonst...

Market News
Bullish
1 hour ago
Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market is projected to grow from $4.8 billion in 2025 to $8.1 billion by 2029, with a CAGR of 13.9%. Growth is fueled by expanding digital credit via mobile money, tighter regulations in Nigeria, Kenya, and Ghana, and inc...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App